From treatment to healing

Towards safe, effective and accessible
psychedelic therapies in Europe

“From a medical care perspective, it is particularly difficult to accept that people continue to suffer because of no or inadequate availability, or the lack of affordability of internationally controlled substances for medical purposes in reliable pharmaceutical quality”.

European Union Statement, Meeting of the UN CND, Vienna, 2020

PSYCHEDELIC ACCESS AND RESEARCH EUROPEAN ALLIANCE - PAREA

We come together to raise awareness, provide evidence-based policy recommendations and accelerate scientific and policy response, leading to the adoption of a holistic approach to psychedelic novel treatments in Europe.

 

Together, we advocate for stepping up European Union’s efforts to thoroughly assess the medicinal benefits of psychedelic compounds as safe, effective, and cost-efficient therapies as well as to better understand and mitigate associated risks. We believe that unlocking the therapeutic potential of psychedelic novel treatments can help millions of Europeans who are in need of better treatment options.

Our Vision

A world in which brain health is valued, preventable suffering is avoided,
and psychedelic treatments help people to heal
and enhance their sense of wellbeing.

Our Members

ecl.png
beckley.png
ebc.png
ecnp.png
https://www.efna.net/
rectangle no bkgrd.png
drugscience.png
Gamian.png
Open-600px (2).png
PsyPAN_logo_highres_smaller (Large).png
PAE logo.png
MIND Foundation Logo_RGB_RGB-Main-Medium (1).png
Norrsken Logo_Full_Black.png

Associate Members and Observers

Associate Member
ICEERS.jpg

Latest News

News
PAREA establishes new governance and leadership at founding General Assembly
PAREA establishes new governance and leadership at founding General Assembly

Today marks an important milestone for PAREA as we elected our new Board of Directors and Office Bearers, and officially established the organisation as a legal non-profit entity, incorporated in Estonia! With three years of impactful work already behind us, this signifies a new step for PAREA, advancing our mission with renewed focus and autonomy.

Read More →
Welcoming UPRA and SIMEPSI to our Community Supporters network
Welcoming UPRA and SIMEPSI to our Community Supporters network

We are delighted to officially announce the joining of two new organisations to the PAREA Community Supporters network - a warm welcome to the Italian Society for Psychedelic Medicine (SIMEPSI) and the Ukrainian Psychedelic Research Association (UPRA)!

Read More →
PAREA co-signs Mental Health Europe statement urging action on promises for mental health
PAREA co-signs Mental Health Europe statement urging action on promises for mental health

PAREA has joined over 55 European organisations in co-signing Mental Health Europe’s joint statement calling for decisive action to deliver on promises made for mental health care.

Read More →
Poland allocates €4 million for clinical trial of psilocybin for treatment-resistant depression
Poland allocates €4 million for clinical trial of psilocybin for treatment-resistant depression

The Medical Research Agency of Poland has announced plans to allocate nearly €4 million for a clinical trial using psilocybin to treat treatment-resistant depression (TRD). Pending regulatory approval, this innovative trial to be conducted by the Medical University of Warsaw, will be one of the first globally to explore how selective serotonin reuptake inhibitors (SSRIs) impact the effectiveness and tolerability of psilocybin treatment for depression.

Read More →
Discussing psychedelic therapies and the PsyPal project on EFNA’s Brain Health Matters podcast
Discussing psychedelic therapies and the PsyPal project on EFNA’s Brain Health Matters podcast

PAREA Founder and Executive Director, Tadeusz Hawrot, recently joined the Brain Health Matters podcast, hosted by the European Federation of Neurological Associations (EFNA), to discuss the topic of psychedelic therapies with the neurology community. Focusing on the episode’s theme of patient involvement in neuroscience research, a central topic of the conversation was the PsyPal project. 

Read More →
Welcoming Francisca Silva to the PAREA team
Welcoming Francisca Silva to the PAREA team

We’re thrilled to welcome Francisca Silva to the PAREA team, joining us as a Project Officer! A neuroscientist by training, Francisca brings a wealth of knowledge and a genuine passion for brain health and mental well-being. Her interdisciplinary academic background includes a dual MSc in Brain and Mind Sciences from University College London (UCL) and Sorbonne Université, along with a BSc from the Maastricht Science Programme…

Read More →